🧠 Neurodiagnoses Clinical Research Platform
Validated tridimensional analysis platform for 22 neurodegenerative diseases. Clinical-grade tools for individual diagnosis, cohort analysis, and pharmaceutical research with regulatory compliance.
FOR RESEARCH USE ONLY - REGULATORY COMPLIANCE REQUIRED
This platform is designed for clinical research and pharmaceutical development. Requires IRB/Ethics Committee approval. Not FDA approved for clinical diagnosis. GCP-compliant data handling and audit trails available.
🧬 Validated Disease-Agnostic Framework
Our peer-reviewed tridimensional framework supports comprehensive evaluation across 22 major neurodegenerative diseases using standardized multi-axis assessment: Genetics → Biomarkers → Neuroimaging → Clinical. Each disease includes validated biomarker profiles, genetic thresholds, and clinical criteria.
Tauopathies (4)
AD, PSP, CBD, Pick
AT(N) framework
Synucleinopathies (3)
PD, DLB, MSA
α-syn RT-QuIC
Ataxias (6)
SCA1-7, FRDA
CAG repeats
Motor Neuron (3)
ALS, SMA, PLS
NfL, TDP-43
FTD Spectrum (3)
FTD, PPA, LATE
TDP-43 pathology
Others (3)
HD, SPG4
Repeat expansions
Individual Analysis
Comprehensive single-patient analysis across all disease categories. Multi-axis evaluation with differential diagnosis.
Cohort Analysis
Batch processing for research cohorts. Upload multiple patients and analyze patterns across disease categories.
Progression Modeling
Simulate disease progression trajectories and explore what-if scenarios for treatment planning and research.
Analysis Interface
Loading analysis interface...